Alzamend Neuro Inc (ALZN) vs Lucyd, Inc (LUCY)

A side-by-side comparison of Alzamend Neuro Inc and Lucyd, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ALZN

Alzamend Neuro Inc

$5M

$1.41HealthcareDelayed quote: Oct 6, 2026, 10:46 AM EDT

LUCY

Lucyd, Inc

$6M

$0.93HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT

Total return — ALZN vs LUCY

growth of $100 · dividends reinvested · last 4y

ALZN -99.9% (-82.2%/yr)LUCY -99.2% (-70.5%/yr)LUCY compounded faster over this window

Log scale — wide-divergence pair

ALZN LUCY

ALZN vs LUCY: by the numbers

•LUCY is the larger company ($6M vs $5M market cap).
•Both run net losses; ALZN's is the smaller (0.00% vs -225.28% net margin).

Metrics side by side

Valuation

Metric	ALZN	LUCY
P/S ratio	N/A	1.71
P/B ratio	0.92	0.85

Profitability

Metric	ALZN	LUCY
Gross margin	0.00%	22.79%
Operating margin	0.00%	-319.16%
Net margin	0.00%	-225.28%
ROE	-156.77%	-111.42%
ROIC	-156.69%	-122.15%

Growth (annualized)

Metric	ALZN	LUCY
Revenue CAGR (5Y)	N/A	64.52%
Total return CAGR (5Y)	-79.14%	N/A

Go deeper

Full ALZN analysis Full LUCY analysis Interactive comparison tool

Dig into the metrics

Alzamend Neuro ROE Lucyd ROE Alzamend Neuro operating margin Lucyd operating margin Alzamend Neuro revenue growth Lucyd revenue growth Alzamend Neuro free cash flow Lucyd free cash flow

Alzamend Neuro & Lucyd appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.